The discovery that certain genes can determine the dosage of the blood-thinning medication warfarin was a landmark for personalized medication and the field of pharmacogenetics. Similar ongoing studies in the field include identifying genetic mutations and their relationship to certain asthma treatments and analyses of mutated DNA in tumors that would allow better calibration for leukemia and lymphoma treatments.

Related Summaries